`571-272-7822
`
`
` Paper 13
` Date: July 20, 2016
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`MYLAN PHARMACEUTICALS INC.
`and MYLAN LABORATORIES LIMITED,
`Petitioner,
`
`v.
`
`UCB PHARMA GMBH,
`Patent Owner.
`____________
`
` Case IPR2016-00510 (Patent 6,858,650 B1)1
`Case IPR2016-00512 (Patent 7,384,980 B2)
`Case IPR2016-00517 (Patent 7,985,772 B2)
`____________
`
`
`Before RAMA G. ELLURU, KRISTINA M. KALAN,
`ROBERT A. POLLOCK, and MICHELLE N. ANKENBRAND,
`Administrative Patent Judges.
`
`KALAN, Administrative Patent Judge.
`
`
`
`
`
`
`SCHEDULING ORDER
`
`
`
`
`1 The parties are not authorized to use this case caption, or to file
`consolidated papers. Any references to a proceeding in the singular herein
`shall be construed to refer to each of the proceedings referenced in this case
`caption.
`
`
`
`IPR2016-00510 (Patent 6,858,650 B1)
`IPR2016-00512 (Patent 7,384,980 B2)
`IPR2016-00517 (Patent 7,985,772 B2)
`
`A. DUE DATES
`This order sets due dates for the parties to take action after institution
`
`of the proceeding(s). The parties may stipulate to different dates for DUE
`
`DATES 1 through 5 (earlier or later, but no later than DUE DATE 6). A
`
`notice of the stipulation, specifically identifying the changed due dates, must
`
`be promptly filed. The parties may not stipulate to an extension of DUE
`
`DATES 6 and 7.
`
`In stipulating to different times, the parties should consider the effect
`
`of the stipulation on times to object to evidence (37 C.F.R. § 42.64(b)(1)), to
`
`supplement evidence (37 C.F.R. § 42.64(b)(2)), to conduct cross-
`
`examination (37 C.F.R. § 42.53(d)(2)), and to draft papers depending on the
`
`evidence and cross-examination testimony (see section B, below).
`
`The parties are reminded that the Testimony Guidelines appended to
`
`the Office Patent Trial Practice Guide, 77 Fed. Reg. 48,756, 48,772
`
`(Aug. 14, 2012) (Appendix D), apply to these proceedings. The Board may
`
`impose an appropriate sanction for failure to adhere to the Testimony
`
`Guidelines. 37 C.F.R. § 42.12. For example, reasonable expenses and
`
`attorneys’ fees incurred by any party may be levied on a person who
`
`impedes, delays, or frustrates the fair examination of a witness.
`
`INITIAL CONFERENCE CALL
`
`The parties are directed to contact the Board within a month of this
`
`decision to schedule an initial conference call if there is a need to discuss
`
`proposed changes to this Scheduling Order or proposed motions. See Office
`
`Patent Trial Practice Guide, 77 Fed. Reg. 48,756, 48,765–66 (Aug. 14, 2012)
`
`(guidance in preparing for the initial conference call).
`
`
`
`2
`
`
`
`IPR2016-00510 (Patent 6,858,650 B1)
`IPR2016-00512 (Patent 7,384,980 B2)
`IPR2016-00517 (Patent 7,985,772 B2)
`
`DUE DATE 1
`The patent owner may file—
`
`a.
`
`b.
`
`A response to the petition (37 C.F.R. § 42.120), and
`
`A motion to amend the patent (37 C.F.R. § 42.121).
`
`The patent owner must file any such response or motion to amend by DUE
`
`DATE 1. The patent owner is reminded that it must confer with the Board
`
`before filing a motion to amend. 37 C.F.R. § 42.121(a). The patent owner
`
`should contact the Board to request any such conference in sufficient time to
`
`ensure that the conference is conducted at least one week before DUE
`
`DATE 1. If the patent owner elects not to file anything, the patent owner
`
`must arrange a conference call with the parties and the Board. The patent
`
`owner is cautioned that any arguments for patentability not raised, or any
`
`evidence not referred to, including declarant testimony, in the response will
`
`be deemed waived.
`
`DUE DATE 2
`The petitioner must file any reply to the patent owner’s response and
`
`opposition to the motion to amend by DUE DATE 2.
`
`DUE DATE 3
`The patent owner must file any reply to the petitioner’s opposition to
`
`patent owner’s motion to amend by DUE DATE 3.
`
`DUE DATE 4
`a.
`Each party must file any motion for an observation on the
`
`cross-examination testimony of a reply witness (see section C, below) by
`
`DUE DATE 4.
`
`
`
`3
`
`
`
`IPR2016-00510 (Patent 6,858,650 B1)
`IPR2016-00512 (Patent 7,384,980 B2)
`IPR2016-00517 (Patent 7,985,772 B2)
`
`
`b.
`
`Each party must file any motion to exclude evidence (37 C.F.R
`
`§ 42.64(c)) and any request for oral argument (37 C.F.R. § 42.70(a)) by
`
`DUE DATE 4.
`
`DUE DATE 5
`a.
`Each party must file any response to an observation on cross-
`
`examination testimony by DUE DATE 5.
`
`b.
`
`Each party must file any opposition to a motion to exclude
`
`evidence by DUE DATE 5.
`
`DUE DATE 6
`Each party must file any reply for a motion to exclude evidence by
`
`DUE DATE 6.
`
`DUE DATE 7
`The oral argument (if requested by either party) is set for DUE
`
`DATE 7.
`
`B. CROSS-EXAMINATION
`Except as the parties might otherwise agree, for each due date—
`
`1.
`
`Cross-examination begins after any supplemental evidence is
`
`due. 37 C.F.R. § 42.53(d)(2).
`
`2.
`
`Cross-examination ends no later than a week before the filing
`
`date for any paper in which the cross-examination testimony is expected to
`
`be used. Id.
`
`C. MOTION FOR OBSERVATION ON CROSS-EXAMINATION
`A motion for observation on cross-examination provides the parties
`
`with a mechanism to draw the Board’s attention to relevant cross-
`
`examination testimony of a reply witness because no further substantive
`
`
`
`4
`
`
`
`IPR2016-00510 (Patent 6,858,650 B1)
`IPR2016-00512 (Patent 7,384,980 B2)
`IPR2016-00517 (Patent 7,985,772 B2)
`
`paper is permitted after the reply. See Office Patent Trial Practice Guide, 77
`
`Fed. Reg. 48,756, 48,768 (Aug. 14, 2012). The observation must be a
`
`concise statement of the relevance of precisely identified testimony to a
`
`precisely identified argument or portion of an exhibit. Each observation
`
`should not exceed a single, short paragraph. The opposing party may
`
`respond to the observation. Any response must be equally concise and
`
`specific.
`
`
`
`
`
`
`
`
`
`5
`
`
`
`IPR2016-00510 (Patent 6,858,650 B1)
`IPR2016-00512 (Patent 7,384,980 B2)
`IPR2016-00517 (Patent 7,985,772 B2)
`
`
`DUE DATE APPENDIX
`
`INITIAL CONFERENCE CALL ............................................... Not required
`
`DUE DATE 1 ...................................................................... October 24, 2016
`Patent owner’s response to the petition
`
`Patent owner’s motion to amend the patent
`
`DUE DATE 2 ....................................................................... January 23, 2017
`Petitioner’s reply to patent owner’s response to petition
`
`Petitioner’s opposition to motion to amend
`
`DUE DATE 3 ..................................................................... February 22, 2017
`Patent owner’s reply to petitioner’s opposition to motion to amend
`
`DUE DATE 4 ........................................................................... March 8, 2017
`Motion for observation regarding cross-examination of reply witness
`
`Motion to exclude evidence
`
`Request for oral argument
`
`DUE DATE 5 ......................................................................... March 22, 2017
`Response to observation
`
`Opposition to motion to exclude
`
`DUE DATE 6 ......................................................................... March 29, 2017
`Reply to opposition to motion to exclude
`
`DUE DATE 7 ............................................................................. April 5, 2017
`Oral argument (if requested)
`
`
`
`
`6
`
`
`
`IPR2016-00510 (Patent 6,858,650 B1)
`IPR2016-00512 (Patent 7,384,980 B2)
`IPR2016-00517 (Patent 7,985,772 B2)
`
`PETITIONER:
`Mitchell Stockwell
`Clay Holloway
`Alyson L. Wooten
`mstockwell@kilpatricktownsend.com
`cholloway@kilpatricktownsend.com
`awooten@kilpatricktownsend.com
`
`
`PATENT OWNER:
`Jeffrey Oelke
`Robert Counihan
`joelke@whitecase.com
`rcounihan@whitecase.com
`
`
`
`
`7
`
`